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The prevalence of anemia and iron deﬁciency is more common
in breastfed infants than their mothers in Bhaktapur, Nepal
RK Chandyo1,2, S Henjum3, M Ulak4, AL Thorne- Lyman5,6, RJ Ulvik7,8, PS Shrestha4, L Locks6, W Fawzi6,9 and TA Strand1,10
BACKGROUND/OBJECTIVES: Iron deﬁciency anemia is a widespread public health problem, particularly in low- and middle-income
countries. Maternal iron status around and during pregnancy may inﬂuence infant iron status. We examined multiple biomarkers to
determine the prevalence of iron deﬁciency and anemia among breastfed infants and explored its relationship with maternal and
infant characteristics in Bhaktapur, Nepal.
SUBJECTS/METHODS: In a cross-sectional survey, we randomly selected 500 mother–infant pairs from Bhaktapur municipality.
Blood was analyzed for hemoglobin, ferritin, total iron-binding capacity, transferrin receptors and C-reactive protein.
RESULTS: The altitude-adjusted prevalence of anemia was 49% among infants 2–6-month-old (hemaglobin (Hb) o10.8 g/dl) and
72% among infants 7–12-month-old (Hb o11.3 g/dl). Iron deﬁciency anemia, deﬁned as anemia and serum ferritin o20 or
o12 μg/l, affected 9 and 26% of infants of these same age groups. Twenty percent of mothers had anemia (Hb o12.3 g/dl), but
only one-ﬁfth was explained by depletion of iron stores. Signiﬁcant predictors of infant iron status and anemia were infant age, sex
and duration of exclusive breastfeeding and maternal ferritin concentrations.
CONCLUSIONS: Our ﬁndings suggest that iron supplementation in pregnancy is likely to have resulted in a low prevalence of
postpartum anemia. The higher prevalence of anemia and iron deﬁciency among breastfed infants compared with their mothers
suggests calls for intervention targeting newborns and infants.
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INTRODUCTION
The World Health Organization (WHO) estimates that globally
~ 293 million young children and 468 million non-pregnant
women suffer from anemia, among which ~ 50% are estimated
to be attributable to iron deﬁciency (ID).1 This makes iron one of
the most common micronutrient deﬁciencies in the world. In
addition to inadequate intake of iron, infection and blood loss are
common causes of ID, and there is growing evidence suggesting
that impairment of mucosal absorption of iron may contribute to
the high rates of ID in developing countries.2 ID impairs physical
activity and cognitive performance and may also cause irreversible
intergenerational effects when it occurs in women of reproductive
age.3,4 ID anemia (IDA) during pregnancy increases the risk of
adverse pregnancy and perinatal outcomes including maternal
and neonatal deaths, particularly in severe anemia.5
Because of limited resources, ID is usually diagnosed based on
the estimation of hemoglobin levels despite the gross lack of
sensitivity and speciﬁcity of this method.6,7 However, there is no
feasible and universally accepted single indicator that can
diagnose ID precisely. Low plasma ferritin indicates depletion of
iron stores, but values between 20 and 100 μg/l are difﬁcult to
interpret because of its nature as a positive acute-phase protein.8
Transferrin receptor (TfR) is a relatively recent addition to the iron
markers and is less affected by inﬂammation. However, it is not as
widely used as ferritin.
Few studies have assessed determinants for poor iron status by
using multiple iron parameters and at the same time measured
the association between maternal iron status and that of their
breastfed infants. The limited knowledge base is drawn primarily
from studies conducted before the universal recommendation of
iron and folic acid supplementation to pregnant women.9
Widespread use of iron and folic acid supplementation during
pregnancy and lactation, secular changes in dietary patterns and
rapid urbanization have likely changed the contributions of ID to
anemia in low- and middle-income countries such as Nepal.10 In
this paper, we aimed to describe prevalence and predictors of
anemia and ID in breastfed infants and explore associations
between maternal and infant iron status in a periurban Nepali
population.
MATERIALS AND METHODS
Study area and population
Bhaktapur municipality is located in the Bhaktapur district in the
Kathmandu valley at an altitude of 1400m above sea level. The population
according to census report of 2011 is 81 748 people, and the majority have
agriculture as their main occupation. The study site includes a periurban
area with a large proportion of low-income inhabitants. Bhaktapur is the
one of the most densely populated districts of Nepal, with a population
density of 11 058 people per square km. Newars constitute ~ 90% of the
Bhaktapur municipality population.11
1Centre for International Health, University of Bergen, Bergen, Norway; 2Department of Community Medicine, Kathmandu Medical College, Sinamangal, Kathmandu, Nepal; 3Oslo
and Akershus University College of Applied Science, Oslo, Norway; 4Department of Child Health, Institute of Medicine, Kathmandu, Nepal; 5WorldFish, Malaysia, Bayan Lepas,
Malaysia; 6Department of Nutrition, Harvard School of Public Health, Boston, MA, USA; 7Department of Clinical Science, University of Bergen, Bergen, Norway; 8Laboratory of
Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway; 9Department of Epidemiology and Global Health and Population, Harvard School of Public Health and
10Innlandet Hospital Trust, Lillehammer, Norway. Correspondence: Dr R Chandyo, Centre for International Health, University of Bergen, PO Box 7800, 5020 Bergen, Norway.
E-mail: ram.chandyo@uib.no
Received 28 October 2014; revised 17 September 2015; accepted 21 September 2015
European Journal of Clinical Nutrition (2015), 1–7
© 2015 Macmillan Publishers Limited All rights reserved 0954-3007/15
www.nature.com/ejcn
Enrollment procedure
The selection criteria and details on ﬁeld procedures have been described
in detail elsewhere.12 From January 2008 to February 2009, we enrolled
500 lactating women between 15 and 44 years of age and 474 of their
infants below 1 year of age from Bhaktapur municipality in Nepal. We used
a two-stage cluster sampling procedure whereby 66 neighborhood streets
called 'Toles' were randomly selected as the primary sampling unit from a
list of 160. We listed all women living in these Toles, and women and infant
pairs were again randomly selected from this list.13 The inclusion criteria
for the study were that both mothers and children had no ongoing
infection (clinically assessed), resided in selected clusters, were willing to
provide the household information and consented to participate. Because
of acute blood loss and many physiological and hormonal changes during
delivery that usually last up to 2 months,14 we enrolled lactating mothers
2 months after delivery. A total of 1101 eligible mother–infant pairs were
recorded during the 1 year of longitudinal follow-up, and 582 were
approached for enrollment. Of these, 500 mother–child pairs were enrolled
in the study and provided a blood sample. All women gave written
informed consent before the start of the study. The study had ethical
clearance from the institutional review boards at the Institute of Medicine,
Kathmandu, Nepal.
Sample size calculations
We assumed a prevalence of anemia of 25% in this population.
Four hundred and ﬁfty mothers were required to detect this prevalence
with an absolute precision of 4%, that is, with a 95% conﬁdence interval
from 21 to 29%. Assuming 10% loss-to-follow-up, we enrolled 500 women
and infant pairs.
Laboratory procedures`
Blood samples were collected from one of the cubital veins using
micronutrient-free heparinized polypropylene tubes (Eppendorf, Sarstedt,
Germany). Hemoglobin was tested on HemoCue immediately after blood
collection (HemoCue, Vedbæk, Denmark) with regular calibration of the
instrument as instructed by the manufacturer. The samples were then
centrifuged (760 g, for 10min, room temperature), and plasma was
allocated onto micronutrient-free polypropylene vials (Eppendorf, Hinz,
Germany) and stored at − 20 °C in a freezer in the ﬁeld site laboratory.
Every day these samples were transported to the central laboratory in
Kathmandu with an ice pack where they were then stored at − 70 °C until
they were transported on dry ice to Norway where they were temporarily
stored at − 80°C before analysis at the Laboratory of Clinical Biochemistry,
Haukeland University Hospital (Bergen, Norway). The biochemical iron
parameters were analyzed on a Modular Analytics System by Roche
Diagnostics (Roche Diagnostics GmbH, Mannheim, Germany) with a
5% coefﬁcient of analytical variation for each test. The plasma ferritin
was analyzed by an electrochemiluminescence immunoassay, whereas the
soluble TfR and transferrin were analyzed by immunoturbidimetry. Total
iron-binding capacity (TIBC) was calculated from transferrin concentrations.
Deﬁnitions
According to the WHO, anemia among infants between 6 and 12 months
of age is deﬁned as hemoglobin o11 g/dl and depleted iron stores if
ferritin o12 μg/l.15 The corresponding cutoffs for non-pregnant women
are 12 g/dl and 15 μg/l, respectively. We also present the prevalence of
depleted stores by plasma ferritin o30 μg/l, which is often used in a
population where infection and inﬂammation are common.1 There is no
standard cutoff to deﬁne anemia among infants o6 months of age;
therefore, we used a cutoff of 10.5 g/dl for Hb and 20 μg/l for ferritin
derived from a study among Swedish and Honduran infants.16 Because of
lower partial pressure of oxygen at higher altitude, Centers for Disease
Control recommends the adjustment of hemoglobin values when
interpreting anemia prevalence among people residing altitude above
1000m of sea level; hence, we added 0.3 g/dl to the standard cutoff values
of Hb to adjust for a local altitude of 1400m.17
To assess iron-deﬁcient erythropoiesis (IDE), which is a transient stage of
cellular iron insufﬁciency that can occur before the development of
anemia, we measured the concentration of soluble TfR.18 TfR concentra-
tions are less affected by inﬂammation than ferritin and can thus reﬂect
early stages of ID at the cellular level provided there are no other causes of
abnormal erythropoiesis.19 There is currently no consensus on a single
cutoff value of TfR used to deﬁne ID, and hence we used thresholds from
similar studies.20–22 We used a concentration of TIBC 483 μmol/l, which is
the upper limit value of our laboratory, to indicate an alteration in iron status.
We deﬁned IDA as the concurrent presence of anemia and low plasma
ferritin or a high TfR concentration. Anemia was considered to have
other causes when it was accompanied with high ferritin or low TfR
concentration.15 The TfR-F ratio was calculated by dividing TfR with the log
transformation of plasma ferritin, and the TfR-F index was calculated by
dividing TfR and ferritin concentrations after converting milligrams of TfR to
microgram units. Maternal body mass index (BMI) was calculated as kg/m2,
and BMI o18.5 kg/m2 was considered as undernourished. For children,
weight for age, length for age and weight for length z-scores were calculated
(WAZ, LAZ and WLZ) based on the WHO growth standards.23
Infants were considered exclusively breastfed when they reportedly had
only consumed breast milk from mother (or wet nurse or expressed breast
milk) since birth and had not consumed any liquids or semi/solid foods,
except medicines.24
Statistical analysis
Differences between subjects with anemia or ID were tested by
independent t-tests for continuous variables and a χ2 test for the
categorical variables. A threshold of Po0.05 was used to indicate
statistical signiﬁcance for all tests. From a list of candidate covariates
including age, gender of infant, C-reactive protein (CRP), breastfeeding
status, anthropometry and socioeconomic factors, as well as mother's age,
BMI and Hb and iron status, we manually selected and run unadjusted
regression analysis.25 A forward purposeful stepwise selection process was
carried out to identify important predictors for each of the iron-related
variables. Only variables that were showing association at Po0.20 were
retained in the ﬁnal regression model. Final predictors for the multiple
linear regression for iron status included infant age and sex, the prevalence
of exclusive breastfeeding at 3 months of age, whether mother received
iron supplements for at least 6 months and maternal ferrritin concentra-
tions. Statistical analysis was performed by using Stata version 10
(StataCorp. 2013. Stata Statistical Software: Release 10.; StataCorp LP,
College Station, TX, USA), and analyses were adjusted for the design effect
of the cluster approach. The graph describing the relationship between
plasma ferritin with age and gender of infant was constructed using
generalized additive models in R statistical software (r-project.org).
RESULTS
Baseline characteristics
The mean age of the 474 infants enrolled in this survey was
6.8 months (ranged 2–12 months), and 45% were below 6 months
of age (Table 1). Most of the infants had been delivered at a
hospital, were fed colostrum and initiated breastfeeding within 1 h
of delivery. However, only 18% of infants practiced exclusive
breastfeeding for the ﬁrst 6 months of life, and average
introduction of semisolid foods mostly in the form of home-
made or local mixed grain porridge (lito) or readymade cerelac
was 3 months.
Iron supplementation was reported by 90% of women during
their last pregnancy, and one-third of them began using it in the
ﬁrst trimester. Although only about a quarter reported taking folic
acid supplementation during their pregnancy, most were likely
not aware that it was included in their iron supplements, as most
preparations in the market combine the two.
Prevalence of anemia and ID
The mean Hb among infants was 10.7 g/dl, and more than
two-thirds of infants 46 months of age (72%) were anemic
(Hb o11.3 g/dl altitude-adjusted). Among infants o6 months of
age, the prevalence of anemia (o10.8 g/dl age- and altitude-
adjusted) was 49%. Only two infants had severe anemia (o7.3 g/dl).
The mean hemoglobin concentration was 13.1 g/dl, and 20% of the
women were found to be anemic using the altitude-speciﬁc cutoff
value of Hb o12.3 g/dl (Tables 2a and b).
Interestingly, only 5% of the women and 17% of the infants
⩽6 months in our study were considered to be iron deﬁcient when
we assessed plasma ferritin with a cutoff of o15 and o20 μg/l,
Anemia and ID among mothers and breastfed infants
RK Chandyo et al
2
European Journal of Clinical Nutrition (2015) 1 – 7 © 2015 Macmillan Publishers Limited
respectively. About one-third of infants 46 months of age (30%)
were iron deﬁcient (plasma ferritin o12 μg/l). When we used a
cutoff value of plasma ferritin o30 μg/l, which was often used in
the population where infection and inﬂammation are common, the
prevalence of ID was 18%, 30% and 71% among mothers, infants
⩽6 months and infants 46 months of age, respectively. Using
combined indicators of hemoglobin and plasma ferritin, the
prevalence of IDA was 4% in mothers and 26% among infants
46 months of age. However, enrolling apparently healthy subjects
and screened clinically, 5% women and 21% infants had a CRP
concentration 45mg/l, suggesting a possible subclinical acute
infection. None of the iron-deﬁcient women were having high CRP
concentration (45mg/l), but 12% of iron-deﬁcient infants of
46 months of age were having high CRP concentration.
After restricting analyses to infants with normal CRP concentration
(CRP o5mg/l), the prevalence of ID and IDA was 19% and 10%
among ⩽ 6 months and 32% and 29% among 46 months,
respectively. Slightly more than one-third (36%) of infants
⩽6 months with normal CRP concentrations had plasma ferritin
concentrations o30 μg/l, but the prevalence was 76% among
46 months of age. The prevalence of IDA in infants ⩽ 6 months
(ferritin o30 μg/l and Hb o10.8 g/dl) was 16% in the whole group
versus 18% in those with normal CRP. Corresponding ﬁgures in
46 months (ferritin o30 μg/l and a slightly higher threshold of Hb
o11.3 g/dl) were 54% and 55%, respectively.
The mean TIBC concentration was 72.7 and 72.6 μmol/l in
mothers and infants, respectively, with increased concentration
483 μmol/l in 15% (n= 77) of the women and 18% (n= 79) of the
infants. Younger women (o25 years of age) were more
vulnerable to ID than older women according to analysis of mean
TfR concentrations (3.7 versus 3.2 mg/l, P= 0.001). Seventy-six
percent of infants (n= 341) and 16% (n= 79) of mothers had IDE
based on the cutoff of TfR 4.4 mg/l. The corresponding ﬁgures
were 14% (n= 61) and 2% (n= 9), respectively, when we used a
cutoff of TfR 8.3 mg/l. Both the ratio of TfR to log ferritin and TfR to
ferritin index showed that fewer than 5% of women were iron
deﬁcient, which is comparable to the estimates derived using
plasma ferritin. The prevalence of ID among infants was 20–76%,
depending mainly on which cutoff value was used for ferritin
(Tables 2a and b).
Six percent of women had combination of high plasma TfR
concentration and anemia, indicating ID at the cellular level.
However, 82% of anemic women did not have a low ferritin
concentration. Similarly, 63% of anemic women did not
have elevated TfR concentrations. Most of the anemic infants
had high TfR concentrations (81%) but not low plasma ferritin
concentrations (24%).
Regression analysis
Results from the multiple regression analyses (Table 3) showed
that each 1-month increase in infant age was associated with a
signiﬁcant decrease in plasma ferritin concentration of 8.2 μg/l
(95% conﬁdence interval: − 10.1, − 6.4). Mean plasma ferritin
concentrations were more than threefold higher among young
infants (6 or o6 months) compared with the older infants
(88.6 μg/l and 26.8 μg/l, P⩽ 0.0001). Figure 1 depicts the associa-
tion between plasma ferritin (restricted among infants with CRP
value of o5mg/l) and child age stratiﬁed according to gender.
Female infants also had signiﬁcantly higher Hb, ferritin and lower
TIBC and TfR concentrations. Age of infants was also positively
associated with TIBC and TfR concentrations. Exclusive breastfeed-
ing for 3 months or more was negatively associated with the
hemoglobin concentration. Maternal ferritin concentrations were
also associated with infant ferritin concentration but not with
other iron parameters.
DISCUSSION
Our ﬁndings from a representative sample of healthy infant and
mother pairs from a periurban municipality in Nepal showed that
anemia is highly prevalent among infants. Maternal iron stores
reﬂected in plasma ferritin concentration offer protection against
infant ID. Yet, even in this setting of greater availability of iron-rich
foods than in many rural areas, the prevalence of anemia among
infants aged 7–12 months is comparable to the most recent DHS
survey in which anemia was observed in 73% and 78% among
9–11- and 6–8-month-old infants, respectively.26
Although we did not collect data on dietary intake of infants
(except breast milk intake and introduction of solid/semisolid
foods), evidence from other studies from Nepal suggests that
dietary diversity is low27 and might also be responsible for IDA in
this population. In Bhaktapur, animal-source foods are often not
fed to young infants because of a general perception that they will
be difﬁcult to digest, which is reﬂected in their high prevalence of
Table 1. Characteristics of infant and mother enrolled in the
micronutrient survey in Bhaktapur, Nepal
Characteristics Valuesa
Infants (n = 474)
Mean age infant (s.d.) (months) 6.8 (2.8)
Mean birth weight (s.d) (g)b 2891 (491)
Newborn with o2500 g of birth weight) (%) 13
Home delivery 10
Initiation of breastfeeding within 1 h (n= 487) 80
Colostrum given 92
Exclusive breastfeeding for 43 months of age 42
Exclusive breastfeeding for 6 months of age 18
Underweight infant (o− 2 z-score weight for age) 5
Stunted infant (o− 2 z-score length for age) 10
Mothers
Mean age mother (s.d., years) 25.8 (4.2)
Mother with o18.5 BMI (kg/m2) 5
Mother with 425 BMI (kg/m2) 17
Mother with two or more parity 59
Mother received large dose of vitamin A in the past
4 months
2
Household information
Living in joint families 51
Family living in only one room 38
Family using tap drinking water 99
Family ownership of land 55
% of illiterate
Mother 19
Father 6
No work or only seasonal agricultural work
Mother 73
Father 7
Family planning
Mother using Depo-Provera (currently) 46
Number of years of previous Depo use, mean (s.d.)c 3.3 (1.8)
Supplementation during the last pregnancy
Mothers with iron supplementation 90
Months of iron supplementation (n= 449), mean (s.d.) 4.8 (1.8)
Months of folic acid supplementation (n= 115),
mean (s.d.)
2.9 (2.2)
Months of calcium supplementation (n= 402),
mean (s.d.)
4.8 (1.8)
Abbreviation: BMI, body mass index. aValues are %, all such cases, unless
otherwise speciﬁed. bAmong 438 newborns where birth weight was
recorded. cAmong 259 mothers who used Depo-Provera injection before.
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cobalamin deﬁciency.12 In the last national survey, iron-rich foods
(meat, ﬁsh, poultry or eggs) were reported only by 13% of infants
in the previous 24 h.26 Besides iron and cobalamin, deﬁciencies of
other nutrients such as vitamin A, C, B9, vitamin D and zinc, as well
as toxicity of lead, may also cause anemia.28,29 Effective mucosal
absorption of iron also may have been impaired by the presence
of inhibiting and/or lack of enhancing factors, as well as intestinal
pararasites and an unfavorable microbiome.2,30
In contrast, the prevalence of maternal anemia in our
population (20%) was lower compared with the national ﬁgure
of 35% for non-pregnant women and is consistent with other
estimates of the prevalence of anemia in the Kathmandu valley.26
Interestingly, ID explained only 20–25% of the total anemia
burden in the women in this study irrespective of the iron
parameters used. The Global Burden of Disease project estimated
that the major causes of anemia among women in South Asia are
ID, sickle cell anemia, thalassemias and malaria.31 However, in
Bhaktapur, malaria, sickle cell disease and thalassemias are
uncommon. More work is needed to identify other possible
causes of anemia in this population, including chronic
enteropathy, as well as other nutritional deﬁciencies such as
vitamin B12 and folate. High coverage of iron supplementation
during the last pregnancy,12 lactation amenorrhea, use of
Depo-Provera family planning injection32 and the local practice
Table 2a. Hb, ferritin, TIBC, TfR and CRP concentrations among healthy infant and lactating mother in Bhaktapur, Nepal
Indicators Infant (2–12 months) Mother (15–44 years)a Spearman's correlation (P-value)b
Hb, n 474 500
Mean, s.d. (g/dl) 10.7 (1.3) 13.1 (1.3) 0.16 (0.01)
Anemia adjusted for altitudec 69 20
Mild anemia (%)c 34 17
Moderate anemia 35 3
Severe anemia 0.4 0
Ferritin, n 448 500
Mean (s.d.) (μg/l) 54.8 (69.8) 68.8 (45.9) 0.12 (0.01)
Depleted iron storesd 20 5
Iron deﬁciency anemiad 17 4
TIBC, n 448 500
Mean (s.d.) (μmol/l) 72.6 (12.1) 72.7 (10.7) 0.09 (0.04)
High TIBC 483 μmol/l 18 15
TfR, n 449 500
Mean (s.d.) (mg/l) 6.2 (3.1) 3.4 (1.5) 0.21 (o0.001)
Iron-deﬁcient erythropoeisise 76 16
Iron-deﬁcient erythropoeisis and anemia 20 6
CRP, n 448 500
Mean (s.d.) (mg/l) 4.3 (10.8) 1.8 (6.5)
4 5mg/l 21 5
Ratio TfR/log ferritin, mean (s.d.)f 2.3 (3.1) 0.95 (0.88)
42 38 5
TfR/ferritin index, mean (s.d.)f 499 (1142) 110 (289)
4500 22 3
Abbreviations: CRP, C-reactive protein; Hb, hemoglobin; TfR, plasma transferrin receptor; TIBC, total iron-binding capacity. aAll values are in %, unless speciﬁed
otherwise. bSpearman's correlation coefﬁcient between mother and their infant iron parameters. cThe cutoffs for altitude-adjusted anemia, mild, moderate and
severe were o12.3 , 10.3–12.2, 7.3–10.2 and o7.3 g/dl among mothers and o11.3, 9.3–11.2, 7.3–9.2 and o7.3 g/dl among infants. dDepleted iron store was
deﬁned as ferritin o15 μg/l among mothers and o12 μg/l for infants. Iron deﬁciency anemia was considered when depleted iron stores were combined with
Hb o12.3 g/dl among mothers and o11.3 g/dl among infants. eIron-deﬁcient erythropoesis was deﬁned TfR values of 44.4 mg/l. fThe TfR-log ferritin ratio
was calculated by dividing TfR with the log transformation of plasma ferritin, and the TfR-ferritin index was calculated by dividing TfR and ferritin
concentrations in microgram unit.
Table 2b. Prevalence of anemia and iron deﬁciency according to age-speciﬁc cutoff values among healthy infants in Bhaktapur, Nepal
State ⩽ 6 months of age 7–12 months of age
1. Anemia (Hb o10.8 g/dl among ⩽ 6 months and o11.3 g/dl among 7–12 months infants) 49% 72%
2. Iron deﬁciency (plasma ferritin o20 μg/l among ⩽ 6 months and o12 μg/l among 7–12 months infants) 17% 30%
3. Iron deﬁciency (plasma ferritin o30 μg/l) 30% 71%
4. Iron deﬁciency anemia (anemia and plasma ferritin o30 μg/l)a 16% 54%
5. Iron deﬁciency anemia (anemia and plasma ferritin o20 μg/l among ⩽ 6 months and o12 μg/l among
7–12 months infants)b
9% 26%
Abbreviation: Hb, hemoglobin. aAmong infants with normal CRP concentrations, IDA was 18% among ⩽ 6 months and 55% among 7–12-month-old infants.
bAmong infants with normal CRP concentrations, IDA was 18% among ⩽ 6 months and 55% among 7–12-month-old infants.
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of giving and withholding certain foods during the postpartum
period may also contribute to the low prevalence of anemia and
ID among women in this population.
Concentrations of Hb and CRP were comparable between male
and female and younger and older (46 months) infants. However,
the average concentrations of plasma ferritin were more than
threefold higher among the young infants (Figure 1) probably due
to temporary redistribution of iron from the red blood cells to the
iron stores during the ﬁrst 6 months of life when fetal hemoglobin
is replaced by adult hemoglobin.16,33 In addition to this
physiological process, the impact of inﬂammation and infectious
diseases on plasma ferritin complicates selection of an adequate
cutoff level to estimate the prevalence of ID and IDA. This is
evident from the ﬁnding that IDA (17%), which did not explain
more than 25% of the total prevalence of anemia (69%) in infants
(Table 2a), was signiﬁcantly increased when we used a ferritin
cutoff of 30 μg/l (Table 2b). Most likely, an important reason for
the discrepancy between prevalence of anemia and IDA is the use
of erroneous ferritin cutoffs, which do not relate adequately to
true ID. This is particularly relevant for infants in the ﬁrst months of
life where 30 μg/l may be is too low with respect to the enlarged
iron stores with median ferritin levels above 80–100 μg/l.33 On the
other hand, despite enrolling clinically healthy children, 21% had
increased CRP. Therefore, we cannot rule out that subclinical, mild
infection may have biased the true ferritin cutoff limit with the
greatest impact in the older infants where the frequency of higher
CRP concentration was higher compared with that in the younger.
Plasma ferritin is very sensitive to infection and may even in mild
virus infection raise 20–60 μg/l above the preclinical baseline.34
The plasma concentration of TfR is increased by ID, but in contrast
to ferritin, it is not seriously affected by infection.19 Among the
infants, there is good consistency between IDA diagnosed
by combining anemia with either increased TfR (i.e., IDE) or with
ferritin o12 μg/l, being 20% and 17%, respectively. As discussed
above, a ferritin cutoff of 12 μg/l is obviously too low; thus, the
prevalence of IDA is likely to be 417%. This point is strongly
supported by the large difference between IDE (76%) and depleted
iron stores (20%). Increased TIBC, which is a measure of long-
standing reduced iron absorption, was increased in 18% of infants,
which corresponded well with our IDA results. Because of lower iron
status and faster growth rate, low birth weight infants are
Figure 1. Association of plasma ferritin concentration and age of
infant according to gender in Bhaktapur, Nepal. Only infants with
C-reactive protein value o5mg/l was included (n= 448). The graph
was made by using generalized additive models in R. The solid
curves depict the estimated mean plasma ferritin concentration;
the shaded areas represent the 95% CIs.
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susceptible for developing ID,35,36 which is also supported by our
data as they had substantially lower Hb concentration compared
with normal weight babies. Our ﬁnding of better iron status
(reﬂecting higher Hb and ferritin and lower TfR and TIBC) among
female infants is also consistent with previous ﬁndings.37–39 This is
perhaps due to differences in iron requirements and metabolism40
or different sized iron stores in early infancy.41 Our ﬁndings of lower
Hb and ferritin concentrations among infants who practiced more
than 3 months of exclusive breastfeeding are also in accordance
with ﬁndings from an earlier study42 and are a reﬂection of the low
iron content of breast milk,43 but in discordance with others.44,45 We
used a cutoff of 3 months for exclusive breastfeeding instead of the
standard WHO recommendation of 6 months. This is because about
50% of our enrolled infants were o6 months of age, and early
introduction of complementary foods or drinks is common in this
population. Caution is required while interpreting these ﬁnding as
we used a strict deﬁnition of exclusive breastfeeding based on any
introduction of food/drink since birth and because feeding patterns
are constantly changing, particularly among young infants.
ID is considered the main underlying cause of anemia in
developing countries. Our study clearly illustrates the well-known
problem of using a common, single cutoff limit to get a true
estimate of the prevalence of IDA and distinguish it from other
causes that include deﬁciencies in other nutrients, inﬂammation,
hematological abnormalities and parasitic infestation.15,46,47 Since
the ﬁnding of an alarmingly high anemia prevalence, particularly
among pregnant women and infants in a micronutrient survey
conducted in 1998,48 the Government of Nepal, in collaboration
with different agencies including the WHO, has endorsed several
strategies to reduce anemia. The strategy includes the following:
daily supplementation with 60 mg elemental iron sulfate for
180 days during pregnancy and the postpartum period irrespec-
tive of baseline iron status; single deworming drugs administered
during the second trimester of pregnancy; insecticide-treated bed
nets in areas where malaria is a common problem;49 and delayed
cord clamping (after 2–3min of birth).50,51 Although we lack data
on trends, our ﬁndings of a relatively low contribution of
iron to overall anemia burden among women, high adherence
to iron supplementation during pregnancy and the positive
association between maternal ferritin with infant plasma ferritin
suggest that these strategies have been effective, at least in the
periurban area of Bhaktapur. Nevertheless, as shown in our study,
combining tests associated with different stages of negative iron
balance makes it possible to discriminate between ID, IDE and IDA.
This may be a valuable approach to target more precisely
subgroups with different need of iron in a population at risk.
CONCLUSION
The prevalence of ID and anemia among infants was high,
particularly among male infants born to mothers with low iron
stores. The contribution of ID to the total anemia prevalence,
particularly among mothers, was low, suggesting that anemia may
have other causes in this community, which require further
exploration. The coverage of iron supplementation among
pregnant and lactating women in this population was high, and
the observation that high maternal plasma ferritin was associated
with lower risk of anemia among infants suggests that increased
coverage of this program in rural Nepal and other parts of South
Asia could help reduce anemia burden.
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